Trial Details
COMPLETEDBasic Information
| Clinical ID | c3436 |
|---|---|
| Identifier | NCT02065570 |
| Trial Title | Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Adalimumab|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-05-01 |
|---|---|
| Primary Completion Date | 2020-01-30 |
| Completion Date | 2020-01-30 |